A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2018; you can also visit the original URL.
The file type is application/pdf
.
Human Telomerase Reverse Transcriptase (hTERT): A Target Molecule for the Treatment of Cisplatin-resistant Tumors
2008
The Korean Journal of Laboratory Medicine
Cisplatin (cis-diammine-dichloro-platinum II ) is one of the most effective chemotherapeutic agents and is widely used for the treatment of malignant tumors, including those found in the testis, head, neck, esophagus, lung, ovaries, 430 Background : Human telomerase reverse transcriptase (hTERT) is a catalytic enzyme that is required for telomerase activity (TA) and cancer progression. Telomerase inhibition or inactivation increases cellular sensitivity to UV irradiation, DNA-damaging agents,
doi:10.3343/kjlm.2008.28.6.430
pmid:19127107
fatcat:2vapuh63l5c5xh23n4ai475shm